November 2, 2022
Dr Vincent Ho is Director at the National Research Foundation (NRF), Singapore. He leads the Human Health and Potential (HHP) Directorate in developing and driving research, innovation and enterprise strategies of Singapore’s HHP domain.
Prior to joining NRF, Dr Ho was an independent Research Fellow in the Molecular Engineering Laboratory founded by the late Nobel Laureate Dr Sydney Brenner. He was a recipient of a National Science Scholarship awarded by the Agency for Science, Technology and Research (A*STAR), Singapore.
Dr Ho received his Ph.D. from the University of Cambridge, and B.Sc. in Chemical Engineering (Magna cum Laude) from the University of Illinois at Urbana-Champaign.
SINGAPORE, 7 July 2022 – MiRXES Pte Ltd, a Singapore-headquartered biotechnology company, whose mission is to save and improve lives through early, actionable, and personalized diagnoses with its innovative RNA-powered cancer early detection solutions, announced today the signing of a Memorandum of Understanding (MOU) that launched Project CADENCE (CAncer Detected Early caN be CurEd). Project CADENCE is the world’s first large-scale clinical research project for the discovery and validation of novel combinations blood-borne circulating microRNA (miRNA) and DNA methylation biomarkers that will lead to the development of a multi-cancer early detection test for up to nine high incidence and high mortality cancers, including lung, breast, colorectal, liver, stomach (gastric), esophageal, ovarian, pancreatic, and prostate cancers.
A new national consortium – the Consortium for Clinical Research and Innovation, Singapore (CRIS) – has been officially launched by the Minister for Health Mr Ong Ye Kung on 6 April 2022 CRIS brings together five key national R&D, clinical translation and service initiatives that will advance clinical research and innovation for Singapore, and establish important capabilities for a future-ready healthcare system